- Home
- GERN vs HBT Comparison
GERN vs HBT Comparison
Compare GERN & HBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- HBT
- Stock Information
- Founded
- GERN 1990
- HBT 1920
- Country
- GERN United States
- HBT United States
- Employees
- GERN 229
- HBT N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- HBT Major Banks
- Sector
- GERN Health Care
- HBT Finance
- Exchange
- GERN Nasdaq
- HBT Nasdaq
- Market Cap
- GERN 823.0M
- HBT 812.0M
- IPO Year
- GERN 1996
- HBT 2019
- Fundamental
- Price
- GERN $1.30
- HBT $25.99
- Analyst Decision
- GERN Buy
- HBT Buy
- Analyst Count
- GERN 8
- HBT 5
- Target Price
- GERN $3.71
- HBT $29.00
- AVG Volume (30 Days)
- GERN 6.6M
- HBT 24.9K
- Earning Date
- GERN 11-06-2025
- HBT 10-20-2025
- Dividend Yield
- GERN N/A
- HBT 3.26%
- EPS Growth
- GERN N/A
- HBT 8.10
- EPS
- GERN N/A
- HBT 2.42
- Revenue
- GERN $164,447,000.00
- HBT $229,851,000.00
- Revenue This Year
- GERN $175.15
- HBT $8.60
- Revenue Next Year
- GERN $56.61
- HBT $2.42
- P/E Ratio
- GERN N/A
- HBT $10.66
- Revenue Growth
- GERN 11877.20
- HBT 4.61
- 52 Week Low
- GERN $1.09
- HBT $19.46
- 52 Week High
- GERN $4.83
- HBT $27.02
- Technical
- Relative Strength Index (RSI)
- GERN 42.28
- HBT 52.31
- Support Level
- GERN $1.27
- HBT $25.51
- Resistance Level
- GERN $1.52
- HBT $26.43
- Average True Range (ATR)
- GERN 0.06
- HBT 0.54
- MACD
- GERN -0.02
- HBT -0.06
- Stochastic Oscillator
- GERN 8.00
- HBT 31.46
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About HBT HBT Financial Inc.
HBT Financial Inc provides a comprehensive suite of business, commercial, wealth management, and retail banking products and services to individuals, businesses, and municipal entities throughout Central and Northeastern Illinois and Eastern Iowa. It operates through one reportable segment: community banking.